Contraception Sample Clauses

Contraception. Food and Drug Administration-approved contraceptive methods, sterilization procedures, and patient education and counseling;
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Contraception. 6.12.1 The Service Provider is required to offer remote assessment and prescribing of contraception and arrange for the dispensing and supply of medication as described in this specification. Medication can be supplied via the post or for collection from a pharmacy. Customers can choose to purchase this component of service and it will therefore not be available to all Service Users. If this is not available, the Service Provider will signpost to other providers of contraception in that area (noting that this could include other e-services).
Sample 1Sample 2Sample 3See All (4)
Contraception. Study therapy may have adverse effects on a fetus in utero. It is not known if pembrolizumab has transient adverse effects on the composition of sperm. Female patients of reproductive potential must agree to use (or have their partner use) acceptable contraception during heterosexual activity to avoid becoming pregnant or impregnating a partner, respectively, while receiving study drug and for 120 days after the last dose of study drug. See Appendix B for acceptable methods of contraception. For this trial, male partners of female patients of child bearing potential will be considered to be of non-reproductive potential if they have azoospermia (whether due to having had a vasectomy or due to an underlying medical condition). Female patients will be considered of non-reproductive potential if they are either: • postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age a high follicle stimulating hormone (FSH) level in the postmenopausal range may be used to confirm a post-menopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient.); or • have had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion, at least 6 weeks prior to screening; or • has a congenital or acquired condition that prevents childbearing.
Sample 1Sample 2
Contraception. The Proposer is using the following methods of contraception on an ongoing basis: . The Proposer will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities: .The Consenter is using the following methods of contraception on an ongoing basis: .The Consenter will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities: .
Sample 1
Contraception. The Proposer is using the following methods of contraception on an ongoing basis: _____________________________________________________________________. The Proposer will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities:
Sample 1
Contraception. Another factor which also does not have scientific agreement is the association between different contraception techniques and disease progression. One study found that implant contraception and injectables were protective of disease progression, while oral contraception was not (Xxxx et al., 2016). A systematic review agrees with the previous study that injectables were associated with protection of disease progression and oral contraception was not associated (Xxxxxxxx, Xxxxx, & Xxxxxx, 2016). This is contrary to another study which did not find an association between hormonal contraceptives (oral, IUDs, and DMPA) and disease progression among women who were not currently on ART (Xxxxxxxx et al., 2016).
Sample 1
Contraception. This study found that men presented themselves as authority figures within sexual partnerships responsible for autocratic (individual), consultative (involved), and collaborative (shared) decision-making regarding fertility behavior and consequently couples’ uptake of family planning. Women presented men as primarily autocratic and sometimes consultative decision-makers about childbearing matters, suggesting that men either make decisions independently or involve their partners, but ultimately make final decisions themselves. Shared decision-making did not seem to be a reality for women. Thanks to a growing body of evidence that men’s and women’s fertility desires often differ, researchers have explored questions around the comparative influence of each partner’s fertility preferences relative to the other. This study’s findings are consistent with those of a study in Kenya, which found that contraceptive uptake was two to three times more likely when husbands rather than wives desired to stop childbearing (Blanc, 2001). Another study in Nigeria found that the husband’s desire for additional children dominated when the number of living children was small, but that the effect of the wife’s desire became greater as the number of living children increased (Blanc, 2001). Future research should explore whether HIV modifies this effect. Family planning interventions could target partners by gender based on a couple’s number of existing children. Because preventing HIV-positive pregnancy is one of the four components of comprehensive PMTCT programs, the ability to control pregnancy is critical for preventing pediatric HIV infections. Most women addressed their lack of control over open fertility decision- making within sexual partnerships by practicing surreptitious fertility decision- making (i.e., covertly practicing family planning with non-visible methods such as intra-uterine devices). Women were able to access family planning in secret thanks to the integration of antenatal care and family planning programs; they either pretended to take their existing children for antenatal services or sought contraception during their children’s actual appointments. However, women expressed concern that they learned about family planning too late (i.e., after getting pregnant and presenting to the antenatal clinic) because there were no spaces for family planning education for childless couples. The practice of covert female- controlled contraception use is well documente...
Sample 1
AutoNDA by SimpleDocs
Contraception. The Proposer is using the following methods of contraception on an ongoing basis:
Sample 1
Contraception. All women of child bearing potential must have a negative pregnancy test performed at screening and at regular intervals throughout the study.
Sample 1

Related to Contraception

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Contracting Authors When the Author is more than one person then, unless otherwise indicated in this Agreement or agreed in writing by the Publisher: (a) the expression “Author” as used in this Agreement will apply collectively for all such persons (each a "co-author"); (b) the Corresponding Author hereby warrants and represents that all co-authors of the contribution have expressly agreed that the Corresponding Author has full right, power and authority to sign this Agreement on their behalf, that the Corresponding Author is entitled to act on their behalf, and that they shall be bound by the Corresponding Author, with respect to all matters, responsibilities, notices and communications related to this Agreement; the Corresponding Author shall obtain authorisations and make them available to the Publisher on request; and (c) each co-author is jointly and severally responsible for the Author’s obligations under this Agreement which apply to each co-author individually and to the co-authors collectively and the Publisher shall not be bound by any separate agreement or legal relationship as between the co-authors. Subject of the Agreement The Author will prepare a contribution provisionally entitled: [Title of the Contribution] The expression “Contribution” as used in this Agreement means the contribution as identified above, and includes without limitation all related material delivered to the Publisher by or on behalf of the Author whatever its media and form (including text, graphical elements, tables, videos and/or links) in all versions and editions in whole or in part. The Contribution may contain links (e.g. frames or in-line links) to media enhancements (e.g. additional documents, tables, diagrams, charts, graphics, illustrations, animations, pictures, videos and/or software) or to social or functional enhancements, complementing the Contribution, which are provided on the Author’s own website or on a third party website or repository (e.g. maintained by an institution) subject always to the Author providing to the Editor, at the latest at the delivery date of the manuscript for the Contribution, an accurate description of each media enhancement and its respective website or repository, including its/their owner, nature and the URL. The Publisher is entitled to reject the inclusion of, or suspend, or delete links to all or any individual media enhancements. In the event that an index is deemed necessary, the Author shall assist the Editor in its preparation (e.g. by suggesting index terms), if requested by the Editor.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • CONTRACT SCOPE Pursuant to this Master Contract, Contractor is authorized to sell and provide only those Goods and/or Services set forth in Exhibit A – Included Goods/Services for the prices set forth in Exhibit B – Prices. Contractor shall not represent to any Purchaser under this Master Contract that Contractor has contractual authority to sell or provide any Goods and/or Services beyond those set forth in Exhibit A – Included Goods/Services.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Contract Work The provision of goods and services identified in the Contract constitute the contract work (Contract Work). Contractor shall perform the Contract Work pursuant to the terms of the Contract. Contractor shall furnish all labor, materials, equipment, tools, transportation, services, appliances, and appurtenances for the Contract Work in strict conformity with this Contract, within the time-period prescribed by the City.

  • Elements Unsatisfactory Needs Improvement Proficient Exemplary IV-A-1. Reflective Practice Demonstrates limited reflection on practice and/or use of insights gained to improve practice. May reflect on the effectiveness of lessons/ units and interactions with students but not with colleagues and/or rarely uses insights to improve practice. Regularly reflects on the effectiveness of lessons, units, and interactions with students, both individually and with colleagues, and uses insights gained to improve practice and student learning. Regularly reflects on the effectiveness of lessons, units, and interactions with students, both individually and with colleagues; and uses and shares with colleagues, insights gained to improve practice and student learning. Is able to model this element.

  • Subcontracting 6.1 The Grantee is responsible for the performance of its obligations under this Agreement, including in relation to any tasks undertaken by subcontractors.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

Time is Money Join Law Insider Premium to draft better contracts faster.